Medicare Enrolled

Dr. Gazala Siddiqui, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6410 FANNIN ST, Houston, TX 77030
8323257131
In practice since 2006 (19 years)
NPI: 1346265725 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Siddiqui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siddiqui? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Siddiqui

Dr. Gazala Siddiqui is an urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Siddiqui performed 495 Medicare services across 452 unique beneficiaries.

Between the years covered by Open Payments, Dr. Siddiqui received a total of $85,436 from 31 pharmaceutical and/or device companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Siddiqui is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 41% volume in TX$ $85,436 industry payments

Medicare Practice Summary

Medicare Utilization ↗
495
Medicare services
Top 41% in TX for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician
452
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Insertion of temporary bladder tube98$35$179
Office visit, established patient (20-29 min)68$64$223
Office visit, established patient (30-39 min)63$95$317
New patient office visit (45-59 min)57$129$379
Automated urinalysis52$2$15
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings30$26$931
Electronic assessment of bladder emptying29$6$314
Insertion of device into abdomen with pressure and urine flow rate study29$159$583
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies24$308$1,257
Office visit, established patient (10-19 min)19$42$139
Fitting and insertion of vaginal support device13$62$237
Pessary, non rubber, any type13$53$149
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$85,436
Total received (2018-2024)
Avg $12,205/year across 7 years
Top 9% in TX for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician
31
Companies
187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$76,556 (89.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,868 (5.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,012 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,263
2023
$47,780
2022
$7,869
2021
$4,786
2020
$7,308
2019
$8,840
2018
$5,590

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$38,858
Sumitomo Pharma America, Inc.
$25,543
Baxter Healthcare
$8,303
UROVANT SCIENCES INC
$6,859
Boston Scientific Corporation
$1,948
Ethicon Inc.
$938
Caldera Medical, Inc
$889
Coloplast Corp
$455
CooperSurgical, Inc.
$382
BOSTON SCIENTIFIC CORPORATION
$378
Renovia Inc
$135
Gynesonics, Inc.
$132
Astellas Pharma Global Development
$104
Smith+Nephew, Inc.
$55
AMAG Pharmaceuticals, Inc.
$53
Hologic Sales and Service, LLC
$41
Bayer HealthCare Pharmaceuticals Inc.
$41
Medtronic, Inc.
$39
Applied Medical Resources Corporation
$39
Aspira Women's Health Inc
$32
AbbVie, Inc.
$31
Duchesnay USA Incorporated
$24
Axonics, Inc.
$21
Olympus America Inc.
$20
Avanos Medical
$19
Exeltis, USA Inc.
$18
Evofem Biosciences, Inc.
$18
Allergan Inc.
$17
TherapeuticsMD, Inc.
$15
Davol Inc.
$15
Hologic, LLC
$14
Top 3 companies account for 85.1% of total payments
Associated products mentioned in payments ›
ADEPT · ALTIS · ARISTA AH FlexiTip · AXIS · Advincula Delineator Uterine Manipulator · Altis · Axonics · BOTOX THERAPEUTIC · DERMABOND Portfolio · Desara · Endosee · FLOSEAL · GEMTESA · GENERAL FEMALE SUI · GENERAL FEMALE SUI · General - Therapies · IMVEXXY · INTRAROSA · Kyleena · Leva Pelvic Floor Trainer · MYOSURE TISSUE REMOVAL DEVICE · MYRBETRIQ · Mirena · Myrbetriq · NovaSure · ON-Q* PUMP AND ACCESSORIES · OVA1 · Orilissa · Osphena · PICO 7 · PICO7 · Phexxi · SEPRAFILM · SOLYX · SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM · SUSPEND · SYMPHION · Solyx SIS System · TRUCLEAR · ThunderBeat · Uterine Manipulators & Injectors · VESICARE · Veozah · Vitafol Fe+
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician in TX.

Equivalent to $17,260 per 100 Medicare services performed
Looking for a urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician in Houston?
Compare urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physicians nearby

Geographic Context

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physicians within 10 mi
14
Per 100K population
0.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Siddiqui is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 9%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Siddiqui experienced with insertion of temporary bladder tube?
Based on Medicare claims data, Dr. Siddiqui performed 98 insertion of temporary bladder tube services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Siddiqui receive payments from pharmaceutical companies?
Yes. Dr. Siddiqui received a total of $85,436 from 31 companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siddiqui's costs compare to other urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physicians in Houston?
Dr. Siddiqui's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siddiqui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →